Intravenous Mesenchymal Stem Cell Administration Modulates Monocytes/Macrophages and Ameliorates Asthmatic Airway Inflammation in a Murine Asthma Model

Although asthma is a common chronic airway disease that responds well to anti-inflammatory agents, some patients with asthma are unresponsive to conventional treatment. Mesenchymal stem cells (MSCs) have therapeutic potential for the treatment of inflammatory diseases owing to their immunomodulatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Yosep, Kang, Sung-Yoon, Bang, Ji-Young, Kim, Yujin, Jeong, Jiung, Jeong, Eui-Man, Kim, Hye Young, Cho, Sang-Heon, Kang, Hye-Ryun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Molecular and Cellular Biology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676992/
https://www.ncbi.nlm.nih.gov/pubmed/36380733
http://dx.doi.org/10.14348/molcells.2022.0038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676992/
https://www.ncbi.nlm.nih.gov/pubmed/36380733
http://dx.doi.org/10.14348/molcells.2022.0038

Ejemplares similares